BioSpace News Archive

Scipher Medicine, developer of a molecular technology platform used to ensure patients are prescribed most effective therapy, today announces the addition of Slava Akmaev, Ph.D. as Chief Technology Officer to the growing leadership team.

Baudax Bio, Inc. today announced the pricing of an underwritten public offering of 7,692,308 shares of its common stock, Series A warrants to purchase 7,692,308 shares of common stock and Series B warrants to purchase 7,692,308 shares of common stock, at an exercise price of $4.59 per share for Series A Warrants and at an exercis

- Agreement to characterize gene expression and immunological signature of tumors - SkylineDx focuses on discovery and development of novel gene-based biomarkers

RLDatix, the leading global provider of intelligent patient safety solutions, announced today that it has acquired Transparent Health Consulting, a firm that focuses on the implementation of communication and patient safety resolution programs in order to respond to and prevent patient harm.

A legal case challenging the safety of water fluoridation which was set for a two-week trial in April in federal district court in San Francisco has been postponed due to the coronavirus outbreak. The case against the EPA was brought by several environmental groups led by Food & Water Watch and Fluoride Action Network (FAN) under pro

Stryker (NYSE:SYK) announced its 2020 Annual Meeting of Shareholders is scheduled as follows:

As health systems across Canada grapple with COVID-19, the Canadian Institute for Health Information has been responding to requests from governments, health systems and the media for relevant data and information to help understand and support decision-making around the pandemic.